Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Refractory seizures as a manifestation of anti-epileptic drug induced hypocalcemia and vitamin D deficiency

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Refractory seizures as a manifestation of anti-epileptic drug induced hypocalcemia and vitamin D deficiency

Study design awaiting verification · JCEM Case Reports · 2026

Original publication title

Refractory seizures as a manifestation of anti-epileptic drug induced hypocalcemia and vitamin D deficiency

Angela Gallucci; Jennifer Bolick; Franklin Thelmo

© The Author(s) 2026. Published by Oxford University Press on behalf of the Endocrine Society.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Abstract

Enzyme-inducing antiepileptic drugs (EIAEDs) such as carbamazepine, phenytoin, phenobarbital, and primidone are used in the management of epilepsy and can alter hepatic enzymes of the cytochrome P450 (CYP450) system. This can have a significant impact on vitamin D metabolism. We describe the case of a 34-year-old female diagnosed with focal epilepsy who presented to the hospital at 25-weeks gestation with recurrent seizures. On admission, she had multiple generalized tonic-clonic seizures with nystagmus requiring repeated rounds of intravenous (IV) medications. The patient was intubated and sedated and brought for emergency caesarean section due to persistent fetal decelerations in the setting of refractory status epilepticus.

Laboratory investigations revealed a serum calcium level of 5.30 mg/dL (SI: 1.32 mmol/L) (reference range, 8.50-10.50 mg/dL [SI: 2.12-2.62 mmol/L]). The patient required numerous antiepileptic infusions for seizure suppression. Further evaluation revealed low 25-hydroxy vitamin D, suggesting significant hypocalcemia and vitamin D deficiency culminating in super-refractory focal status epilepticus due to chronic EIAED use. This case underscores the need to maintain a high index of suspicion for metabolic disturbances in patients on long-term EIAED therapy with regular monitoring of vitamin D and calcium levels to prevent complications.

Authors’ abstract

Abstract

Enzyme-inducing antiepileptic drugs (EIAEDs) such as carbamazepine, phenytoin, phenobarbital, and primidone are used in the management of epilepsy and can alter hepatic enzymes of the cytochrome P450 (CYP450) system. This can have a significant impact on vitamin D metabolism. We describe the case of a 34-year-old female diagnosed with focal epilepsy who presented to the hospital at 25-weeks gestation with recurrent seizures. On admission, she had multiple generalized tonic-clonic seizures with nystagmus requiring repeated rounds of intravenous (IV) medications. The patient was intubated and sedated and brought for emergency caesarean section due to persistent fetal decelerations in the setting of refractory status epilepticus.

Laboratory investigations revealed a serum calcium level of 5.30 mg/dL (SI: 1.32 mmol/L) (reference range, 8.50-10.50 mg/dL [SI: 2.12-2.62 mmol/L]). The patient required numerous antiepileptic infusions for seizure suppression. Further evaluation revealed low 25-hydroxy vitamin D, suggesting significant hypocalcemia and vitamin D deficiency culminating in super-refractory focal status epilepticus due to chronic EIAED use. This case underscores the need to maintain a high index of suspicion for metabolic disturbances in patients on long-term EIAED therapy with regular monitoring of vitamin D and calcium levels to prevent complications.

Publication and source details

Original title: Refractory seizures as a manifestation of anti-epileptic drug induced hypocalcemia and vitamin D deficiency

Angela Gallucci; Jennifer Bolick; Franklin Thelmo

JCEM Case Reports · 2026

Correspondence: Angela Gallucci, MD, Department of Internal Medicine, Christiana Care Hospital, 4755 Ogletown Stanton Rd, Newark, DE 19718, USA. Email: angela.gallucci@christianacare.org.© The Author(s) 2026. Published by Oxford University Press on behalf of the Endocrine Society.2026https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. See the journal About page for additional terms.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T10:34:20.011937+00:00

DOI: 10.1210/jcemcr/luag126 · PMC13171436